In March 2025, the company declared new options for any immediate-to-purchaser providing of its Wegovy weight loss drug. The company set up a new pharmacy, called NovoCare, which would cost shoppers $499 every month for use of the drug, less than fifty percent the price of the drug by means of other pharmaceutical distribution networks.[fifty three